Ionis Pharmaceuticals | IONS - Current Liabilities


Ionis Pharmaceuticals reported $315.64M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agios Pharmaceuticals USD 70.22M 11.37M Jun/2026
Alnylam Pharmaceuticals USD 1.51B 163.04M Jun/2026
Arrowhead Research USD 295.22M 52.2M Mar/2026
Astellas Pharma JPY 1.22T 106.19B Mar/2026
BioCryst Pharmaceuticals USD 195.39M 675K Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Exelixis USD 370.98M 34.67M Mar/2026
Halozyme Therapeutics USD 363.21M 186.12M Mar/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 2.53B 139M Jun/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Neurocrine Biosciences USD 874.5M 42.8M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Omeros USD 85.5M 2.28M Jun/2025
OPKO Health USD 148.38M 1.71M Mar/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pfizer USD 34.35B 2.64B Mar/2026
Pharma Mar EUR 98.42M 9.2M Jun/2026
PTC Therapeutics USD 771.07M 152.54M Jun/2026
Qiagen NV USD 479.11M 33.03M Mar/2026
Regeneron Pharmaceuticals USD 5.53B 422.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 1.44B 668.7M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tilray USD 259.32M 8.32M Sep/2025
Ultragenyx Pharmaceutical USD 325M 59M Mar/2026
Vertex Pharmaceuticals USD 3.88B 19.4M Mar/2026
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026